Playful digital illustration of a magenta smartphone-rocket launching from a 5G tower, surrounded by floating dollar signs and SIM cards, symbolizing T-Mobile’s growth, profits, and CEO confidence.

New CEO Buys TMUS: Insider Confidence or Lost Contacts?

New T-Mobile CEO Srini Gopalan wasted no time showing confidence — buying nearly $2 million of TMUS stock right after taking charge. With record customer growth, a raised outlook, and juicy cash flow, the question is: smart signal or misdialed enthusiasm? 📱💰

 

Read entire article

Blackstone investor snapshot: Breyer’s insider buy, strong AUM, dry powder, and growth pillars in PE, real estate, credit, infrastructure

Investor & Insider James Breyer Just Bought Blackstone (BX). Should You Sip the Alt-Assets Kool-Aid—or Sit It Out?

Blackstone remains the alt-assets apex predator: $1.24T AUM, rising perpetual capital, and a fresh insider buy from director James Breyer. We unpack fundraising momentum, distributable earnings, variable dividends, key risks (rates, exits), and why dips may be gifts for long-term investors.

 

Read entire article

Briefcase atop a skyline of REITs and infrastructure with a “BUY” ticket—signaling insider conviction, real-asset focus, and earnings leverage.

Cohen & Steers (CNS): Chairman Buys Millions—Time To Clip the Coupon or Clip Your Wings?

CNS shows mid-single-digit revenue growth, double-digit EPS growth, and a fresh $2.85M insider buy. Real-asset optionality, de-foamed multiple, TL;DR + FAQs.

 

Read entire article

Iridium-style LEO satellite beaming coverage to the whole globe with IoT and phone icons—signaling global reach, D2D potential, and investor focus on valuation.

CEO Bought Shares At Twice Today’s Price: Time To Buy Iridium Communications (IRDM)?

CEO bought at ~$37; shares now ~$19. We break down Iridium’s moat, IoT and PNT/D2D bets, valuation reset, and key risks—without the rocket emojis (ok, a few).

 

Read entire article

A playful digital illustration showund. Behind him, a rollercoaster-shaped stock chart rises, dips, and teases a reing a cartoon CEO holding a giant prescription bottle labeled

Viatris: The CEO Just Bought Shares… Should You Pop a Pill or Press "Buy"?

When a CEO personally buys over half a million dollars of stock, it’s time to pay attention. Viatris (VTRS) may be undervalued, with insider confidence, institutional backing, and a promising drug pipeline. But big losses and high debt mean it’s not risk-free. Is now the time to nibble?

Read entire article